1.68
price down icon1.75%   -0.03
 
loading
Precedente Chiudi:
$1.71
Aprire:
$1.66
Volume 24 ore:
1,994
Relative Volume:
0.19
Capitalizzazione di mercato:
$7.73M
Reddito:
$4.33M
Utile/perdita netta:
$-4.17M
Rapporto P/E:
-1.1235
EPS:
-1.4953
Flusso di cassa netto:
$-3.19M
1 W Prestazione:
-10.40%
1M Prestazione:
-39.57%
6M Prestazione:
-22.94%
1 anno Prestazione:
-42.66%
Intervallo 1D:
Value
$1.66
$1.71
Intervallo di 1 settimana:
Value
$1.60
$1.85
Portata 52W:
Value
$1.45
$3.20

Biomerica Inc Stock (BMRA) Company Profile

Name
Nome
Biomerica Inc
Name
Telefono
(949) 379-2875
Name
Indirizzo
17571 VON KARMAN AVENUE, IRVINE, CA
Name
Dipendente
50
Name
Cinguettio
@biomerica_inc
Name
Prossima data di guadagno
null
Name
Ultimi documenti SEC
Name
BMRA's Discussions on Twitter

Compare BMRA vs ABT, MDT, SYK, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
BMRA icon
BMRA
Biomerica Inc
1.68 7.73M 4.33M -4.17M -3.19M -1.4953
ABT icon
ABT
Abbott Laboratories
102.51 177.38B 46.59B 5.41B 7.38B 3.0938
MDT icon
MDT
Medtronic Plc
96.59 123.55B 36.36B 4.84B 5.43B 3.7261
SYK icon
SYK
Stryker Corp
307.08 117.79B 25.27B 3.34B 4.57B 8.6334
BSX icon
BSX
Boston Scientific Corp
46.01 66.68B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
90.09 51.93B 6.30B 1.07B 1.09B 1.8406

Biomerica Inc Stock (BMRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-05-05 Iniziato Citizens Mkt Outperform
2020-11-10 Iniziato Colliers Securities Buy
2018-01-04 Iniziato B. Riley FBR, Inc. Buy

Biomerica Inc Borsa (BMRA) Ultime notizie

pulisher
Oct 18, 2026

Biomerica Q1FY27 Results: Net loss $1.2M, revenue falls 8% YoY - scanx.trade

Oct 18, 2026
pulisher
Oct 16, 2026

Biomerica, Inc. Posts $1.23 Million Fiscal First-Quarter Loss as Sales Fall 8% - TOKENPOST

Oct 16, 2026
pulisher
Oct 16, 2026

Diagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders - TradingView

Oct 16, 2026
pulisher
Oct 16, 2026

Biomerica Reports First Quarter Fiscal 2027 Financial Results - The Manila Times

Oct 16, 2026
pulisher
Oct 16, 2026

Biomerica Reports First Quarter Fiscal 2027 Financial Results - The Manila Times

Oct 16, 2026
pulisher
Oct 16, 2026

BRIEF-Biomerica Q1 Net Income USD -1.2 Million - TradingView

Oct 16, 2026
pulisher
Oct 15, 2026

BIOMERICA INC 1Q FY2027: Revenue $1.27M, EPS $(0.37) — 10-Q Summary - TradingView

Oct 15, 2026
pulisher
Oct 15, 2026

Compensation chair will not stand for re-election at Biomerica (BMRA)'s December 11 annual meeting. - Stock Titan

Oct 15, 2026
pulisher
Oct 15, 2026

Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2026 - www.marketscreener.com

Oct 15, 2026
pulisher
Oct 08, 2026

BIOMERICA INC SEC Filing (Oct 8, 2026) - Stock Titan

Oct 08, 2026
pulisher
Oct 08, 2026

BIOMERICA INC SEC Filing (Oct 8, 2026) - Stock Titan

Oct 08, 2026
pulisher
Sep 28, 2026

CEO and directors bought into Biomerica (BMRA)'s $2.23 million share sale. - Stock Titan

Sep 28, 2026
pulisher
Sep 26, 2026

Form S-3 Biomerica Inc For: 26 September By Investing.com - Investing.com Nigeria

Sep 26, 2026
pulisher
Sep 25, 2026

Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants - TradingView

Sep 25, 2026
pulisher
Sep 25, 2026

Biomerica Files $250 Million Mixed Shelf - marketscreener.com

Sep 25, 2026
pulisher
Sep 25, 2026

Biomerica Files $250 Million Mixed Shelf - Yahoo Finance

Sep 25, 2026
pulisher
Sep 24, 2026

Form S-3 Biomerica Inc For: 24 September - Investing.com India

Sep 24, 2026
pulisher
Sep 24, 2026

Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com Nigeria

Sep 24, 2026
pulisher
Sep 24, 2026

Form S-3 Biomerica Inc For: 24 September By Investing.com - Investing.com UK

Sep 24, 2026
pulisher
Sep 24, 2026

Biomerica files prospectus for resale of 1.4 million shares - scanx.trade

Sep 24, 2026
pulisher
Sep 18, 2026

Biomerica Stock Price Forecast. Should You Buy BMRA? - StockInvest.us

Sep 18, 2026
pulisher
Sep 17, 2026

Biomerica Inc. (BMRA) Holds Near $2.36 as Traders Eye Tight RangeDiamond Pattern - siam.in

Sep 17, 2026
pulisher
Sep 10, 2026

Biomerica (BMRA) gets new B. Riley-linked shareholder - stocktitan.net

Sep 10, 2026
pulisher
Sep 08, 2026

Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan

Sep 08, 2026
pulisher
Sep 07, 2026

Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal

Sep 07, 2026
pulisher
Sep 04, 2026

Biomerica (BMRA) Gains 1.35% as Shares Test Key Level Near $2.36Cash Secured Put - dars.gov.et

Sep 04, 2026
pulisher
Sep 03, 2026

BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Loo - GuruFocus

Sep 03, 2026
pulisher
Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Nigeria

Sep 02, 2026
pulisher
Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Australia

Sep 02, 2026
pulisher
Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com

Sep 02, 2026
pulisher
Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com India

Sep 02, 2026
pulisher
Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Canada

Sep 02, 2026
pulisher
Sep 02, 2026

Biomerica net loss hits USD 3.8M in 2026 - Medical Buyer

Sep 02, 2026
pulisher
Sep 01, 2026

BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media

Sep 01, 2026
pulisher
Sep 01, 2026

Biomerica reports fiscal 2026 revenue and product updates - grafa.com

Sep 01, 2026
pulisher
Sep 01, 2026

Biomerica Reports Q4 Results - Orange County Business Journal

Sep 01, 2026
pulisher
Sep 01, 2026

Biomerica Q4 net loss narrows 27%, revenue up 17% to $875K - scanx.trade

Sep 01, 2026
pulisher
Sep 01, 2026

Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative

Sep 01, 2026
pulisher
Sep 01, 2026

Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative

Sep 01, 2026
pulisher
Aug 31, 2026

BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com

Aug 31, 2026
pulisher
Aug 31, 2026

Biomerica announces USD 2.23M financing - medicalbuyer.co.in

Aug 31, 2026
pulisher
Aug 30, 2026

Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Aug 30, 2026
pulisher
Aug 28, 2026

B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan

Aug 28, 2026
pulisher
Aug 28, 2026

Biomerica Inc. (BMRA) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com

Aug 28, 2026
pulisher
Aug 28, 2026

BRC Group Holdings Secures Board Representation at Biomerica with 10.03% Stake - TradingView

Aug 28, 2026
pulisher
Aug 27, 2026

Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com Canada

Aug 27, 2026
pulisher
Aug 27, 2026

Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com South Africa

Aug 27, 2026
pulisher
Aug 27, 2026

Biomerica director Gary Huff buys $50,000 in common stock By Investing.com - Investing.com India

Aug 27, 2026
pulisher
Aug 27, 2026

Biomerica (BMRA) director joins $1.60 private placement buy - Stock Titan

Aug 27, 2026

Biomerica Inc Azioni (BMRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Biomerica Inc Azioni (BMRA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MOATAZEDI DAVID
Director
Aug 26 '26
Buy
1.60
10,000
16,000
40,625
Chin Eric
Director
Aug 26 '26
Buy
1.60
6,250
10,000
38,750
BARBIERI ALLEN
Executive Vice Chairman
Aug 26 '26
Buy
1.60
20,000
32,000
73,542
Irani Zackary S.
Chief Executive Officer
Aug 26 '26
Buy
1.60
31,250
50,000
242,570
$0.98
price up icon 7.54%
$7.51
price down icon 3.10%
$1.685
price down icon 2.60%
$0.1691
price up icon 1.62%
WOK WOK
$1.13
price down icon 4.24%
$2.50
price down icon 2.72%
Capitalizzazione:     |  Volume (24 ore):